img

Global β-Lactam Antibiotics Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global β-Lactam Antibiotics Market Insights, Forecast to 2034

β-lactam antibiotics refer to a large class of antibiotics with a β-lactam ring in their chemical structure. These antibiotics have the advantages of strong bactericidal activity, low toxicity, wide indications and good clinical efficacy.
Global β-Lactam Antibiotics market is expected to reach to US$ 28520 million in 2024, with a positive growth of %, compared with US$ 27220 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, β-Lactam Antibiotics industry is evaluated to reach US$ 37790 million in 2029. The CAGR will be 4.8% during 2024 to 2029.
Antibiotics are a class of secondary metabolites produced by microorganisms (including bacteria, fungi, actinomycetes) or higher animals and plants in the course of life, which have anti-pathogen or other activities, and can interfere with the development and function of other living cells. . There are many kinds of antibiotics, which are mainly divided into two categoriesß-lactams and non-ß-lactams. Among them, ß-lactams have the most varieties and are the most widely used in clinical practice. From the perspective of medication structure, β-lactam antibiotics accounted for 55% of the anti-infective drugs in China. With the gradual recovery of the global economy, the continuous growth of the total population and the improvement of the aging society, the scale of the global pharmaceutical market has maintained a steady growth. From the perspective of the terminal market, the current global market size of antibiotic preparations is about 50 billion US dollars. Antibiotic products and markets are relatively mature, but due to the rigid demand for antibiotics in clinical treatment, the industry still shows a low growth trend.
Report Covers
This report presents an overview of global β-Lactam Antibiotics market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global β-Lactam Antibiotics market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


ACS Dobfar
CSPC
United Laboratories
Novartis
LKPC
Changsheng Pharma
North China Pharmaceuticals
Centrient Pharmaceutical
Aurobindo Pharma
Yili Chuanning Biotechnology
Jiangxi Fushine Pharmaceutical
QILU Pharmaceutical
Jiangxi Huabang Pharmaceutical
Segment by Type
Penicillin
Oxycephems
Carbapenems
Cephalosporins
Others

Segment by Application


Hospital
Clinic

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ β-Lactam Antibiotics plant distribution, commercial date of β-Lactam Antibiotics, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, β-Lactam Antibiotics introduction, etc. β-Lactam Antibiotics Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of β-Lactam Antibiotics
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 β-Lactam Antibiotics Product Introduction
1.2 Market by Type
1.2.1 Global β-Lactam Antibiotics Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Penicillin
1.2.3 Oxycephems
1.2.4 Carbapenems
1.2.5 Cephalosporins
1.2.6 Others
1.3 Market by Application
1.3.1 Global β-Lactam Antibiotics Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global β-Lactam Antibiotics Sales Estimates and Forecasts 2018-2029
2.2 Global β-Lactam Antibiotics Revenue by Region
2.2.1 Global β-Lactam Antibiotics Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global β-Lactam Antibiotics Revenue by Region (2018-2024)
2.2.3 Global β-Lactam Antibiotics Revenue by Region (2024-2029)
2.2.4 Global β-Lactam Antibiotics Revenue Market Share by Region (2018-2029)
2.3 Global β-Lactam Antibiotics Sales Estimates and Forecasts 2018-2029
2.4 Global β-Lactam Antibiotics Sales by Region
2.4.1 Global β-Lactam Antibiotics Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global β-Lactam Antibiotics Sales by Region (2018-2024)
2.4.3 Global β-Lactam Antibiotics Sales by Region (2024-2029)
2.4.4 Global β-Lactam Antibiotics Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global β-Lactam Antibiotics Sales by Manufacturers
3.1.1 Global β-Lactam Antibiotics Sales by Manufacturers (2018-2024)
3.1.2 Global β-Lactam Antibiotics Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of β-Lactam Antibiotics in 2022
3.2 Global β-Lactam Antibiotics Revenue by Manufacturers
3.2.1 Global β-Lactam Antibiotics Revenue by Manufacturers (2018-2024)
3.2.2 Global β-Lactam Antibiotics Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by β-Lactam Antibiotics Revenue in 2022
3.3 Global Key Players of β-Lactam Antibiotics, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global β-Lactam Antibiotics Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global β-Lactam Antibiotics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of β-Lactam Antibiotics, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of β-Lactam Antibiotics, Product Offered and Application
3.8 Global Key Manufacturers of β-Lactam Antibiotics, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global β-Lactam Antibiotics Sales by Type
4.1.1 Global β-Lactam Antibiotics Historical Sales by Type (2018-2024)
4.1.2 Global β-Lactam Antibiotics Forecasted Sales by Type (2024-2029)
4.1.3 Global β-Lactam Antibiotics Sales Market Share by Type (2018-2029)
4.2 Global β-Lactam Antibiotics Revenue by Type
4.2.1 Global β-Lactam Antibiotics Historical Revenue by Type (2018-2024)
4.2.2 Global β-Lactam Antibiotics Forecasted Revenue by Type (2024-2029)
4.2.3 Global β-Lactam Antibiotics Revenue Market Share by Type (2018-2029)
4.3 Global β-Lactam Antibiotics Price by Type
4.3.1 Global β-Lactam Antibiotics Price by Type (2018-2024)
4.3.2 Global β-Lactam Antibiotics Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global β-Lactam Antibiotics Sales by Application
5.1.1 Global β-Lactam Antibiotics Historical Sales by Application (2018-2024)
5.1.2 Global β-Lactam Antibiotics Forecasted Sales by Application (2024-2029)
5.1.3 Global β-Lactam Antibiotics Sales Market Share by Application (2018-2029)
5.2 Global β-Lactam Antibiotics Revenue by Application
5.2.1 Global β-Lactam Antibiotics Historical Revenue by Application (2018-2024)
5.2.2 Global β-Lactam Antibiotics Forecasted Revenue by Application (2024-2029)
5.2.3 Global β-Lactam Antibiotics Revenue Market Share by Application (2018-2029)
5.3 Global β-Lactam Antibiotics Price by Application
5.3.1 Global β-Lactam Antibiotics Price by Application (2018-2024)
5.3.2 Global β-Lactam Antibiotics Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada β-Lactam Antibiotics Market Size by Type
6.1.1 US & Canada β-Lactam Antibiotics Sales by Type (2018-2029)
6.1.2 US & Canada β-Lactam Antibiotics Revenue by Type (2018-2029)
6.2 US & Canada β-Lactam Antibiotics Market Size by Application
6.2.1 US & Canada β-Lactam Antibiotics Sales by Application (2018-2029)
6.2.2 US & Canada β-Lactam Antibiotics Revenue by Application (2018-2029)
6.3 US & Canada β-Lactam Antibiotics Market Size by Country
6.3.1 US & Canada β-Lactam Antibiotics Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada β-Lactam Antibiotics Sales by Country (2018-2029)
6.3.3 US & Canada β-Lactam Antibiotics Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe β-Lactam Antibiotics Market Size by Type
7.1.1 Europe β-Lactam Antibiotics Sales by Type (2018-2029)
7.1.2 Europe β-Lactam Antibiotics Revenue by Type (2018-2029)
7.2 Europe β-Lactam Antibiotics Market Size by Application
7.2.1 Europe β-Lactam Antibiotics Sales by Application (2018-2029)
7.2.2 Europe β-Lactam Antibiotics Revenue by Application (2018-2029)
7.3 Europe β-Lactam Antibiotics Market Size by Country
7.3.1 Europe β-Lactam Antibiotics Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe β-Lactam Antibiotics Sales by Country (2018-2029)
7.3.3 Europe β-Lactam Antibiotics Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China β-Lactam Antibiotics Market Size
8.1.1 China β-Lactam Antibiotics Sales (2018-2029)
8.1.2 China β-Lactam Antibiotics Revenue (2018-2029)
8.2 China β-Lactam Antibiotics Market Size by Application
8.2.1 China β-Lactam Antibiotics Sales by Application (2018-2029)
8.2.2 China β-Lactam Antibiotics Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia β-Lactam Antibiotics Market Size by Type
9.1.1 Asia β-Lactam Antibiotics Sales by Type (2018-2029)
9.1.2 Asia β-Lactam Antibiotics Revenue by Type (2018-2029)
9.2 Asia β-Lactam Antibiotics Market Size by Application
9.2.1 Asia β-Lactam Antibiotics Sales by Application (2018-2029)
9.2.2 Asia β-Lactam Antibiotics Revenue by Application (2018-2029)
9.3 Asia β-Lactam Antibiotics Sales by Region
9.3.1 Asia β-Lactam Antibiotics Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia β-Lactam Antibiotics Revenue by Region (2018-2029)
9.3.3 Asia β-Lactam Antibiotics Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America β-Lactam Antibiotics Market Size by Type
10.1.1 Middle East, Africa and Latin America β-Lactam Antibiotics Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America β-Lactam Antibiotics Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America β-Lactam Antibiotics Market Size by Application
10.2.1 Middle East, Africa and Latin America β-Lactam Antibiotics Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America β-Lactam Antibiotics Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America β-Lactam Antibiotics Sales by Country
10.3.1 Middle East, Africa and Latin America β-Lactam Antibiotics Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America β-Lactam Antibiotics Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America β-Lactam Antibiotics Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 ACS Dobfar
11.1.1 ACS Dobfar Company Information
11.1.2 ACS Dobfar Overview
11.1.3 ACS Dobfar β-Lactam Antibiotics Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 ACS Dobfar β-Lactam Antibiotics Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 ACS Dobfar Recent Developments
11.2 CSPC
11.2.1 CSPC Company Information
11.2.2 CSPC Overview
11.2.3 CSPC β-Lactam Antibiotics Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 CSPC β-Lactam Antibiotics Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 CSPC Recent Developments
11.3 United Laboratories
11.3.1 United Laboratories Company Information
11.3.2 United Laboratories Overview
11.3.3 United Laboratories β-Lactam Antibiotics Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 United Laboratories β-Lactam Antibiotics Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 United Laboratories Recent Developments
11.4 Novartis
11.4.1 Novartis Company Information
11.4.2 Novartis Overview
11.4.3 Novartis β-Lactam Antibiotics Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Novartis β-Lactam Antibiotics Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Novartis Recent Developments
11.5 LKPC
11.5.1 LKPC Company Information
11.5.2 LKPC Overview
11.5.3 LKPC β-Lactam Antibiotics Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 LKPC β-Lactam Antibiotics Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 LKPC Recent Developments
11.6 Changsheng Pharma
11.6.1 Changsheng Pharma Company Information
11.6.2 Changsheng Pharma Overview
11.6.3 Changsheng Pharma β-Lactam Antibiotics Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Changsheng Pharma β-Lactam Antibiotics Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Changsheng Pharma Recent Developments
11.7 North China Pharmaceuticals
11.7.1 North China Pharmaceuticals Company Information
11.7.2 North China Pharmaceuticals Overview
11.7.3 North China Pharmaceuticals β-Lactam Antibiotics Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 North China Pharmaceuticals β-Lactam Antibiotics Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 North China Pharmaceuticals Recent Developments
11.8 Centrient Pharmaceutical
11.8.1 Centrient Pharmaceutical Company Information
11.8.2 Centrient Pharmaceutical Overview
11.8.3 Centrient Pharmaceutical β-Lactam Antibiotics Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Centrient Pharmaceutical β-Lactam Antibiotics Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Centrient Pharmaceutical Recent Developments
11.9 Aurobindo Pharma
11.9.1 Aurobindo Pharma Company Information
11.9.2 Aurobindo Pharma Overview
11.9.3 Aurobindo Pharma β-Lactam Antibiotics Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Aurobindo Pharma β-Lactam Antibiotics Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Aurobindo Pharma Recent Developments
11.10 Yili Chuanning Biotechnology
11.10.1 Yili Chuanning Biotechnology Company Information
11.10.2 Yili Chuanning Biotechnology Overview
11.10.3 Yili Chuanning Biotechnology β-Lactam Antibiotics Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 Yili Chuanning Biotechnology β-Lactam Antibiotics Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Yili Chuanning Biotechnology Recent Developments
11.11 Jiangxi Fushine Pharmaceutical
11.11.1 Jiangxi Fushine Pharmaceutical Company Information
11.11.2 Jiangxi Fushine Pharmaceutical Overview
11.11.3 Jiangxi Fushine Pharmaceutical β-Lactam Antibiotics Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 Jiangxi Fushine Pharmaceutical β-Lactam Antibiotics Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Jiangxi Fushine Pharmaceutical Recent Developments
11.12 QILU Pharmaceutical
11.12.1 QILU Pharmaceutical Company Information
11.12.2 QILU Pharmaceutical Overview
11.12.3 QILU Pharmaceutical β-Lactam Antibiotics Sales, Price, Revenue and Gross Margin (2018-2024)
11.12.4 QILU Pharmaceutical β-Lactam Antibiotics Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 QILU Pharmaceutical Recent Developments
11.13 Jiangxi Huabang Pharmaceutical
11.13.1 Jiangxi Huabang Pharmaceutical Company Information
11.13.2 Jiangxi Huabang Pharmaceutical Overview
11.13.3 Jiangxi Huabang Pharmaceutical β-Lactam Antibiotics Sales, Price, Revenue and Gross Margin (2018-2024)
11.13.4 Jiangxi Huabang Pharmaceutical β-Lactam Antibiotics Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Jiangxi Huabang Pharmaceutical Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 β-Lactam Antibiotics Industry Chain Analysis
12.2 β-Lactam Antibiotics Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 β-Lactam Antibiotics Production Mode & Process
12.4 β-Lactam Antibiotics Sales and Marketing
12.4.1 β-Lactam Antibiotics Sales Channels
12.4.2 β-Lactam Antibiotics Distributors
12.5 β-Lactam Antibiotics Customers
13 Market Dynamics
13.1 β-Lactam Antibiotics Industry Trends
13.2 β-Lactam Antibiotics Market Drivers
13.3 β-Lactam Antibiotics Market Challenges
13.4 β-Lactam Antibiotics Market Restraints
14 Key Findings in The Global β-Lactam Antibiotics Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global β-Lactam Antibiotics Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Penicillin
Table 3. Major Manufacturers of Oxycephems
Table 4. Major Manufacturers of Carbapenems
Table 5. Major Manufacturers of Cephalosporins
Table 6. Major Manufacturers of Others
Table 7. Global β-Lactam Antibiotics Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 8. Global β-Lactam Antibiotics Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 9. Global β-Lactam Antibiotics Revenue by Region (2018-2024) & (US$ Million)
Table 10. Global β-Lactam Antibiotics Revenue by Region (2024-2029) & (US$ Million)
Table 11. Global β-Lactam Antibiotics Revenue Market Share by Region (2018-2024)
Table 12. Global β-Lactam Antibiotics Revenue Market Share by Region (2024-2029)
Table 13. Global β-Lactam Antibiotics Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 14. Global β-Lactam Antibiotics Sales by Region (2018-2024) & (K Units)
Table 15. Global β-Lactam Antibiotics Sales by Region (2024-2029) & (K Units)
Table 16. Global β-Lactam Antibiotics Sales Market Share by Region (2018-2024)
Table 17. Global β-Lactam Antibiotics Sales Market Share by Region (2024-2029)
Table 18. Global β-Lactam Antibiotics Sales by Manufacturers (2018-2024) & (K Units)
Table 19. Global β-Lactam Antibiotics Sales Share by Manufacturers (2018-2024)
Table 20. Global β-Lactam Antibiotics Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 21. Global β-Lactam Antibiotics Revenue Share by Manufacturers (2018-2024)
Table 22. Global Key Players of β-Lactam Antibiotics, Industry Ranking, 2021 VS 2022 VS 2024
Table 23. β-Lactam Antibiotics Price by Manufacturers 2018-2024 (US$/Unit)
Table 24. Global β-Lactam Antibiotics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 25. Global β-Lactam Antibiotics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in β-Lactam Antibiotics as of 2022)
Table 26. Global Key Manufacturers of β-Lactam Antibiotics, Manufacturing Base Distribution and Headquarters
Table 27. Global Key Manufacturers of β-Lactam Antibiotics, Product Offered and Application
Table 28. Global Key Manufacturers of β-Lactam Antibiotics, Date of Enter into This Industry
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global β-Lactam Antibiotics Sales by Type (2018-2024) & (K Units)
Table 31. Global β-Lactam Antibiotics Sales by Type (2024-2029) & (K Units)
Table 32. Global β-Lactam Antibiotics Sales Share by Type (2018-2024)
Table 33. Global β-Lactam Antibiotics Sales Share by Type (2024-2029)
Table 34. Global β-Lactam Antibiotics Revenue by Type (2018-2024) & (US$ Million)
Table 35. Global β-Lactam Antibiotics Revenue by Type (2024-2029) & (US$ Million)
Table 36. Global β-Lactam Antibiotics Revenue Share by Type (2018-2024)
Table 37. Global β-Lactam Antibiotics Revenue Share by Type (2024-2029)
Table 38. β-Lactam Antibiotics Price by Type (2018-2024) & (US$/Unit)
Table 39. Global β-Lactam Antibiotics Price Forecast by Type (2024-2029) & (US$/Unit)
Table 40. Global β-Lactam Antibiotics Sales by Application (2018-2024) & (K Units)
Table 41. Global β-Lactam Antibiotics Sales by Application (2024-2029) & (K Units)
Table 42. Global β-Lactam Antibiotics Sales Share by Application (2018-2024)
Table 43. Global β-Lactam Antibiotics Sales Share by Application (2024-2029)
Table 44. Global β-Lactam Antibiotics Revenue by Application (2018-2024) & (US$ Million)
Table 45. Global β-Lactam Antibiotics Revenue by Application (2024-2029) & (US$ Million)
Table 46. Global β-Lactam Antibiotics Revenue Share by Application (2018-2024)
Table 47. Global β-Lactam Antibiotics Revenue Share by Application (2024-2029)
Table 48. β-Lactam Antibiotics Price by Application (2018-2024) & (US$/Unit)
Table 49. Global β-Lactam Antibiotics Price Forecast by Application (2024-2029) & (US$/Unit)
Table 50. US & Canada β-Lactam Antibiotics Sales by Type (2018-2024) & (K Units)
Table 51. US & Canada β-Lactam Antibiotics Sales by Type (2024-2029) & (K Units)
Table 52. US & Canada β-Lactam Antibiotics Revenue by Type (2018-2024) & (US$ Million)
Table 53. US & Canada β-Lactam Antibiotics Revenue by Type (2024-2029) & (US$ Million)
Table 54. US & Canada β-Lactam Antibiotics Sales by Application (2018-2024) & (K Units)
Table 55. US & Canada β-Lactam Antibiotics Sales by Application (2024-2029) & (K Units)
Table 56. US & Canada β-Lactam Antibiotics Revenue by Application (2018-2024) & (US$ Million)
Table 57. US & Canada β-Lactam Antibiotics Revenue by Application (2024-2029) & (US$ Million)
Table 58. US & Canada β-Lactam Antibiotics Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 59. US & Canada β-Lactam Antibiotics Revenue by Country (2018-2024) & (US$ Million)
Table 60. US & Canada β-Lactam Antibiotics Revenue by Country (2024-2029) & (US$ Million)
Table 61. US & Canada β-Lactam Antibiotics Sales by Country (2018-2024) & (K Units)
Table 62. US & Canada β-Lactam Antibiotics Sales by Country (2024-2029) & (K Units)
Table 63. Europe β-Lactam Antibiotics Sales by Type (2018-2024) & (K Units)
Table 64. Europe β-Lactam Antibiotics Sales by Type (2024-2029) & (K Units)
Table 65. Europe β-Lactam Antibiotics Revenue by Type (2018-2024) & (US$ Million)
Table 66. Europe β-Lactam Antibiotics Revenue by Type (2024-2029) & (US$ Million)
Table 67. Europe β-Lactam Antibiotics Sales by Application (2018-2024) & (K Units)
Table 68. Europe β-Lactam Antibiotics Sales by Application (2024-2029) & (K Units)
Table 69. Europe β-Lactam Antibiotics Revenue by Application (2018-2024) & (US$ Million)
Table 70. Europe β-Lactam Antibiotics Revenue by Application (2024-2029) & (US$ Million)
Table 71. Europe β-Lactam Antibiotics Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 72. Europe β-Lactam Antibiotics Revenue by Country (2018-2024) & (US$ Million)
Table 73. Europe β-Lactam Antibiotics Revenue by Country (2024-2029) & (US$ Million)
Table 74. Europe β-Lactam Antibiotics Sales by Country (2018-2024) & (K Units)
Table 75. Europe β-Lactam Antibiotics Sales by Country (2024-2029) & (K Units)
Table 76. China β-Lactam Antibiotics Sales by Type (2018-2024) & (K Units)
Table 77. China β-Lactam Antibiotics Sales by Type (2024-2029) & (K Units)
Table 78. China β-Lactam Antibiotics Revenue by Type (2018-2024) & (US$ Million)
Table 79. China β-Lactam Antibiotics Revenue by Type (2024-2029) & (US$ Million)
Table 80. China β-Lactam Antibiotics Sales by Application (2018-2024) & (K Units)
Table 81. China β-Lactam Antibiotics Sales by Application (2024-2029) & (K Units)
Table 82. China β-Lactam Antibiotics Revenue by Application (2018-2024) & (US$ Million)
Table 83. China β-Lactam Antibiotics Revenue by Application (2024-2029) & (US$ Million)
Table 84. Asia β-Lactam Antibiotics Sales by Type (2018-2024) & (K Units)
Table 85. Asia β-Lactam Antibiotics Sales by Type (2024-2029) & (K Units)
Table 86. Asia β-Lactam Antibiotics Revenue by Type (2018-2024) & (US$ Million)
Table 87. Asia β-Lactam Antibiotics Revenue by Type (2024-2029) & (US$ Million)
Table 88. Asia β-Lactam Antibiotics Sales by Application (2018-2024) & (K Units)
Table 89. Asia β-Lactam Antibiotics Sales by Application (2024-2029) & (K Units)
Table 90. Asia β-Lactam Antibiotics Revenue by Application (2018-2024) & (US$ Million)
Table 91. Asia β-Lactam Antibiotics Revenue by Application (2024-2029) & (US$ Million)
Table 92. Asia β-Lactam Antibiotics Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 93. Asia β-Lactam Antibiotics Revenue by Region (2018-2024) & (US$ Million)
Table 94. Asia β-Lactam Antibiotics Revenue by Region (2024-2029) & (US$ Million)
Table 95. Asia β-Lactam Antibiotics Sales by Region (2018-2024) & (K Units)
Table 96. Asia β-Lactam Antibiotics Sales by Region (2024-2029) & (K Units)
Table 97. Middle East, Africa and Latin America β-Lactam Antibiotics Sales by Type (2018-2024) & (K Units)
Table 98. Middle East, Africa and Latin America β-Lactam Antibiotics Sales by Type (2024-2029) & (K Units)
Table 99. Middle East, Africa and Latin America β-Lactam Antibiotics Revenue by Type (2018-2024) & (US$ Million)
Table 100. Middle East, Africa and Latin America β-Lactam Antibiotics Revenue by Type (2024-2029) & (US$ Million)
Table 101. Middle East, Africa and Latin America β-Lactam Antibiotics Sales by Application (2018-2024) & (K Units)
Table 102. Middle East, Africa and Latin America β-Lactam Antibiotics Sales by Application (2024-2029) & (K Units)
Table 103. Middle East, Africa and Latin America β-Lactam Antibiotics Revenue by Application (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America β-Lactam Antibiotics Revenue by Application (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America β-Lactam Antibiotics Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 106. Middle East, Africa and Latin America β-Lactam Antibiotics Revenue by Country (2018-2024) & (US$ Million)
Table 107. Middle East, Africa and Latin America β-Lactam Antibiotics Revenue by Country (2024-2029) & (US$ Million)
Table 108. Middle East, Africa and Latin America β-Lactam Antibiotics Sales by Country (2018-2024) & (K Units)
Table 109. Middle East, Africa and Latin America β-Lactam Antibiotics Sales by Country (2024-2029) & (K Units)
Table 110. ACS Dobfar Company Information
Table 111. ACS Dobfar Description and Major Businesses
Table 112. ACS Dobfar β-Lactam Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 113. ACS Dobfar β-Lactam Antibiotics Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. ACS Dobfar Recent Developments
Table 115. CSPC Company Information
Table 116. CSPC Description and Major Businesses
Table 117. CSPC β-Lactam Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 118. CSPC β-Lactam Antibiotics Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. CSPC Recent Developments
Table 120. United Laboratories Company Information
Table 121. United Laboratories Description and Major Businesses
Table 122. United Laboratories β-Lactam Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 123. United Laboratories β-Lactam Antibiotics Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. United Laboratories Recent Developments
Table 125. Novartis Company Information
Table 126. Novartis Description and Major Businesses
Table 127. Novartis β-Lactam Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 128. Novartis β-Lactam Antibiotics Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Novartis Recent Developments
Table 130. LKPC Company Information
Table 131. LKPC Description and Major Businesses
Table 132. LKPC β-Lactam Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 133. LKPC β-Lactam Antibiotics Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. LKPC Recent Developments
Table 135. Changsheng Pharma Company Information
Table 136. Changsheng Pharma Description and Major Businesses
Table 137. Changsheng Pharma β-Lactam Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 138. Changsheng Pharma β-Lactam Antibiotics Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Changsheng Pharma Recent Developments
Table 140. North China Pharmaceuticals Company Information
Table 141. North China Pharmaceuticals Description and Major Businesses
Table 142. North China Pharmaceuticals β-Lactam Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 143. North China Pharmaceuticals β-Lactam Antibiotics Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. North China Pharmaceuticals Recent Developments
Table 145. Centrient Pharmaceutical Company Information
Table 146. Centrient Pharmaceutical Description and Major Businesses
Table 147. Centrient Pharmaceutical β-Lactam Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 148. Centrient Pharmaceutical β-Lactam Antibiotics Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Centrient Pharmaceutical Recent Developments
Table 150. Aurobindo Pharma Company Information
Table 151. Aurobindo Pharma Description and Major Businesses
Table 152. Aurobindo Pharma β-Lactam Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 153. Aurobindo Pharma β-Lactam Antibiotics Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. Aurobindo Pharma Recent Developments
Table 155. Yili Chuanning Biotechnology Company Information
Table 156. Yili Chuanning Biotechnology Description and Major Businesses
Table 157. Yili Chuanning Biotechnology β-Lactam Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 158. Yili Chuanning Biotechnology β-Lactam Antibiotics Product Model Numbers, Pictures, Descriptions and Specifications
Table 159. Yili Chuanning Biotechnology Recent Developments
Table 160. Jiangxi Fushine Pharmaceutical Company Information
Table 161. Jiangxi Fushine Pharmaceutical Description and Major Businesses
Table 162. Jiangxi Fushine Pharmaceutical β-Lactam Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 163. Jiangxi Fushine Pharmaceutical β-Lactam Antibiotics Product Model Numbers, Pictures, Descriptions and Specifications
Table 164. Jiangxi Fushine Pharmaceutical Recent Developments
Table 165. QILU Pharmaceutical Company Information
Table 166. QILU Pharmaceutical Description and Major Businesses
Table 167. QILU Pharmaceutical β-Lactam Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 168. QILU Pharmaceutical β-Lactam Antibiotics Product Model Numbers, Pictures, Descriptions and Specifications
Table 169. QILU Pharmaceutical Recent Developments
Table 170. Jiangxi Huabang Pharmaceutical Company Information
Table 171. Jiangxi Huabang Pharmaceutical Description and Major Businesses
Table 172. Jiangxi Huabang Pharmaceutical β-Lactam Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 173. Jiangxi Huabang Pharmaceutical β-Lactam Antibiotics Product Model Numbers, Pictures, Descriptions and Specifications
Table 174. Jiangxi Huabang Pharmaceutical Recent Developments
Table 175. Key Raw Materials Lists
Table 176. Raw Materials Key Suppliers Lists
Table 177. β-Lactam Antibiotics Distributors List
Table 178. β-Lactam Antibiotics Customers List
Table 179. β-Lactam Antibiotics Market Trends
Table 180. β-Lactam Antibiotics Market Drivers
Table 181. β-Lactam Antibiotics Market Challenges
Table 182. β-Lactam Antibiotics Market Restraints
Table 183. Research Programs/Design for This Report
Table 184. Key Data Information from Secondary Sources
Table 185. Key Data Information from Primary Sources
List of Figures
Figure 1. β-Lactam Antibiotics Product Picture
Figure 2. Global β-Lactam Antibiotics Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global β-Lactam Antibiotics Market Share by Type in 2022 & 2029
Figure 4. Penicillin Product Picture
Figure 5. Oxycephems Product Picture
Figure 6. Carbapenems Product Picture
Figure 7. Cephalosporins Product Picture
Figure 8. Others Product Picture
Figure 9. Global β-Lactam Antibiotics Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 10. Global β-Lactam Antibiotics Market Share by Application in 2022 & 2029
Figure 11. Hospital
Figure 12. Clinic
Figure 13. β-Lactam Antibiotics Report Years Considered
Figure 14. Global β-Lactam Antibiotics Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global β-Lactam Antibiotics Revenue 2018-2029 (US$ Million)
Figure 16. Global β-Lactam Antibiotics Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 17. Global β-Lactam Antibiotics Revenue Market Share by Region (2018-2029)
Figure 18. Global β-Lactam Antibiotics Sales 2018-2029 ((K Units)
Figure 19. Global β-Lactam Antibiotics Sales Market Share by Region (2018-2029)
Figure 20. US & Canada β-Lactam Antibiotics Sales YoY (2018-2029) & (K Units)
Figure 21. US & Canada β-Lactam Antibiotics Revenue YoY (2018-2029) & (US$ Million)
Figure 22. Europe β-Lactam Antibiotics Sales YoY (2018-2029) & (K Units)
Figure 23. Europe β-Lactam Antibiotics Revenue YoY (2018-2029) & (US$ Million)
Figure 24. China β-Lactam Antibiotics Sales YoY (2018-2029) & (K Units)
Figure 25. China β-Lactam Antibiotics Revenue YoY (2018-2029) & (US$ Million)
Figure 26. Asia (excluding China) β-Lactam Antibiotics Sales YoY (2018-2029) & (K Units)
Figure 27. Asia (excluding China) β-Lactam Antibiotics Revenue YoY (2018-2029) & (US$ Million)
Figure 28. Middle East, Africa and Latin America β-Lactam Antibiotics Sales YoY (2018-2029) & (K Units)
Figure 29. Middle East, Africa and Latin America β-Lactam Antibiotics Revenue YoY (2018-2029) & (US$ Million)
Figure 30. The β-Lactam Antibiotics Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 31. The Top 5 and 10 Largest Manufacturers of β-Lactam Antibiotics in the World: Market Share by β-Lactam Antibiotics Revenue in 2022
Figure 32. Global β-Lactam Antibiotics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 33. Global β-Lactam Antibiotics Sales Market Share by Type (2018-2029)
Figure 34. Global β-Lactam Antibiotics Revenue Market Share by Type (2018-2029)
Figure 35. Global β-Lactam Antibiotics Sales Market Share by Application (2018-2029)
Figure 36. Global β-Lactam Antibiotics Revenue Market Share by Application (2018-2029)
Figure 37. US & Canada β-Lactam Antibiotics Sales Market Share by Type (2018-2029)
Figure 38. US & Canada β-Lactam Antibiotics Revenue Market Share by Type (2018-2029)
Figure 39. US & Canada β-Lactam Antibiotics Sales Market Share by Application (2018-2029)
Figure 40. US & Canada β-Lactam Antibiotics Revenue Market Share by Application (2018-2029)
Figure 41. US & Canada β-Lactam Antibiotics Revenue Share by Country (2018-2029)
Figure 42. US & Canada β-Lactam Antibiotics Sales Share by Country (2018-2029)
Figure 43. U.S. β-Lactam Antibiotics Revenue (2018-2029) & (US$ Million)
Figure 44. Canada β-Lactam Antibiotics Revenue (2018-2029) & (US$ Million)
Figure 45. Europe β-Lactam Antibiotics Sales Market Share by Type (2018-2029)
Figure 46. Europe β-Lactam Antibiotics Revenue Market Share by Type (2018-2029)
Figure 47. Europe β-Lactam Antibiotics Sales Market Share by Application (2018-2029)
Figure 48. Europe β-Lactam Antibiotics Revenue Market Share by Application (2018-2029)
Figure 49. Europe β-Lactam Antibiotics Revenue Share by Country (2018-2029)
Figure 50. Europe β-Lactam Antibiotics Sales Share by Country (2018-2029)
Figure 51. Germany β-Lactam Antibiotics Revenue (2018-2029) & (US$ Million)
Figure 52. France β-Lactam Antibiotics Revenue (2018-2029) & (US$ Million)
Figure 53. U.K. β-Lactam Antibiotics Revenue (2018-2029) & (US$ Million)
Figure 54. Italy β-Lactam Antibiotics Revenue (2018-2029) & (US$ Million)
Figure 55. Russia β-Lactam Antibiotics Revenue (2018-2029) & (US$ Million)
Figure 56. China β-Lactam Antibiotics Sales Market Share by Type (2018-2029)
Figure 57. China β-Lactam Antibiotics Revenue Market Share by Type (2018-2029)
Figure 58. China β-Lactam Antibiotics Sales Market Share by Application (2018-2029)
Figure 59. China β-Lactam Antibiotics Revenue Market Share by Application (2018-2029)
Figure 60. Asia β-Lactam Antibiotics Sales Market Share by Type (2018-2029)
Figure 61. Asia β-Lactam Antibiotics Revenue Market Share by Type (2018-2029)
Figure 62. Asia β-Lactam Antibiotics Sales Market Share by Application (2018-2029)
Figure 63. Asia β-Lactam Antibiotics Revenue Market Share by Application (2018-2029)
Figure 64. Asia β-Lactam Antibiotics Revenue Share by Region (2018-2029)
Figure 65. Asia β-Lactam Antibiotics Sales Share by Region (2018-2029)
Figure 66. Japan β-Lactam Antibiotics Revenue (2018-2029) & (US$ Million)
Figure 67. South Korea β-Lactam Antibiotics Revenue (2018-2029) & (US$ Million)
Figure 68. China Taiwan β-Lactam Antibiotics Revenue (2018-2029) & (US$ Million)
Figure 69. Southeast Asia β-Lactam Antibiotics Revenue (2018-2029) & (US$ Million)
Figure 70. India β-Lactam Antibiotics Revenue (2018-2029) & (US$ Million)
Figure 71. Middle East, Africa and Latin America β-Lactam Antibiotics Sales Market Share by Type (2018-2029)
Figure 72. Middle East, Africa and Latin America β-Lactam Antibiotics Revenue Market Share by Type (2018-2029)
Figure 73. Middle East, Africa and Latin America β-Lactam Antibiotics Sales Market Share by Application (2018-2029)
Figure 74. Middle East, Africa and Latin America β-Lactam Antibiotics Revenue Market Share by Application (2018-2029)
Figure 75. Middle East, Africa and Latin America β-Lactam Antibiotics Revenue Share by Country (2018-2029)
Figure 76. Middle East, Africa and Latin America β-Lactam Antibiotics Sales Share by Country (2018-2029)
Figure 77. Brazil β-Lactam Antibiotics Revenue (2018-2029) & (US$ Million)
Figure 78. Mexico β-Lactam Antibiotics Revenue (2018-2029) & (US$ Million)
Figure 79. Turkey β-Lactam Antibiotics Revenue (2018-2029) & (US$ Million)
Figure 80. Israel β-Lactam Antibiotics Revenue (2018-2029) & (US$ Million)
Figure 81. GCC Countries β-Lactam Antibiotics Revenue (2018-2029) & (US$ Million)
Figure 82. β-Lactam Antibiotics Value Chain
Figure 83. β-Lactam Antibiotics Production Process
Figure 84. Channels of Distribution
Figure 85. Distributors Profiles
Figure 86. Bottom-up and Top-down Approaches for This Report
Figure 87. Data Triangulation
Figure 88. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries